logo

Abiomed Inc. (ABMD)



Trade ABMD now with
  Date
  Headline
11/1/2022 7:04:46 AM ABIOMED Q2 Revenue Of $266 Mln, Increase Of 11% In Constant Currency, Or 7% On Reported Basis
11/1/2022 6:34:38 AM Johnson & Johnson To Acquire Abiomed For An Upfront Payment Of $380/Shr Cash
8/4/2022 7:46:42 AM Abiomed Inc. Q1 Earnings Summary
8/4/2022 7:03:46 AM Amended: ABIOMED, Inc. Q1 EPS $1.19 Vs Loss/shr $0.59 Last Year
4/28/2022 7:06:26 AM Abiomed Q4 EPS $1.31; Adj EPS $1.16
2/3/2022 7:23:51 AM Abiomed Inc. (ABMD) Has Raised Its FY22 EPS Estimate To $1025 - $1030 From $1010 - $1030 Mln
2/3/2022 7:06:12 AM ABIOMED Q3 Revenue $261 Mln, Increase Of 13% From Prior Year
10/28/2021 7:07:28 AM Abiomed Q2 Net Income $57.0 Mln Or $1.24/shr Vs. $62.2 Mln Or $1.36/shr Last Year
8/18/2021 8:07:44 AM Abiomed : FDA Grants Breakthrough Device Designation To Impella ECP, Smallest Heart Pump